Trial Profile
Clinical Trials Insight: 700059332
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Sep 2010
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Glucagon-like peptide 1 agonist (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 16 Sep 2010 New trial record
- 14 Sep 2010 Results reported in a TransPharma Medical media release.